to Highlight Recently Announced Iomab-ACT Trial with Leading FDA Approved Commercial CAR T-Cell Therapy Being Led by the University of Texas Southwestern
ir.actiniumpharma.com/press-releases/detail/475
ir.actiniumpharma.com/press-releases/detail/475